Skip to main content

WORK PACKAGE 4

WP4: Managing comorbidities

The goal of WORKPACKAGE 4 is to develop and evaluate strategies for optimal prevention and treatment of cardiovascular disease in rheumatology and musculoskeletal disorders. In addition, the goal is to find ways to identify and treat other important comorbidities such as lung disease, kidney disease, diabetes, osteoporosis, gastrointestinal disease, and depression.

More about the projects that are part of or associated with WORK PACKAGE 4:

WP1 - Optimized medical interventions

ARCTIC FORWARD

10-year follow-up of patients with rheumatoid arthritis who received structured treatment-to-target therapy in the early phase of the disease.

WP1 - Optimized medical interventions

ARCTIC REWIND extension study

Long-term follow-up of patients with well-controlled rheumatoid arthritis - the ARCTIC REWIND extension study

WP2 - PPhenotyping for personalized medicine

BOOGIE

Dynamics in BOne turnover markers in relation to Glucocorticoid treatment in patients with an Inflammatory joint disEase

WP4 - Management of additional diseases

The Diet Study

In a large randomized international study, we will assess whether 4-minute short information sessions on heart-healthy eating have the same effect as individually tailored 60-minute dietary guidance.

WP4 - Management of additional diseases

ESPA

Exercise as a treatment for patients with inflammatory rheumatic disease

WP4 - Management of additional diseases

ExeHeart

Better cardiovascular health for patients with inflammatory joint disease

WP4 - Management of additional diseases

Rheumatic heart disease registry

 The Norwegian Cardio-Rheuma register

WP6 - Dechiphering long-term outcomes

NOR-DMARD

The Norwegian register for antirheumatic drugs.

WP4 - Management of additional diseases

SURF-PsA

Investigation of risk factors in psoriatic arthritis. 

WP4 - Management of additional diseases

SURF-RA

Investigation of risk factors for rheumatoid arthritis

WP4 - Management of additional diseases

Exercise interventions in spondyloarthritis

 

WP1 - Optimized medical interventions

ZEBRA

Zoledronate early to hip fracture patients - safe and effective? A double-blind randomized controlled treatment strategy trial on zoledronate in hip fracture patients